Skip to content
Recall Observatory FDA recall evidence

Drug product

Artesunate for Injection, 110 mg/vial, packaged in a) 2x2 pack containing 2 Single-dose vials artesunate (73607-001-01) and 2 vials sterile diluent (NDC 73607-001-02) per carton (NDC 73607-001-11); 4x4 pack containing 4 Single-dose vials artesunate (73607-001-01) and 4 vials sterile diluent (NDC 73607-001-02) per carton (NDC 73607-001-10), Rx only, Mfg for: Amivas, LLC, 1209 Orange St., Wilmington, Delaware 19801.

D-0002-2022

September 27, 2021

Class II

Product summary

Firm
AMIVAS (US), LLC
Event
Event 88772
Status
Terminated
Classification
Class II
Quantity
292 cartons
Official record key
drug-enforcement:D-0002-2022

Official wording

Reason: Lack of Assurance of Sterility: Air filter failed post integrity test leading to a lack of sterility assurance.

Code information: Manufacturer Lot Numbers: AR479E01, exp. date 11/03/2022; AR479E02, exp. date 11/09/2022; AR479E03, exp. date 11/16/2022; Cardinal Health Packaging Solutions Lot Numbers: 7507001 and 7508001

Distribution pattern: Product was distributed to 3 major distributors who may have further distributed the product to various medical centers, hospitals and hospital pharmacies nationwide in the USA.

Derived failure modes

  • Sterility assurance

    reason.sterility_assurance · v1.0.0

    Lack of Assurance of Sterility